Alexandra MacLean - Chief Executive Officer, Director at AVENUE THERAPEUTICS, INC.

Issuer-level insider activity

Role
Chief Executive Officer, Director
Issuer ticker
ATXI on OTC
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Alexandra MacLean since 13 Sep 2025

Reported holdings for Alexandra MacLean in AVENUE THERAPEUTICS, INC.

Form 4 holding Chief Executive Officer, Director

AVENUE THERAPEUTICS, INC.

Security class
COMMON STOCK, PAR VALUE $0.0001
Shares / value
170,000
Estimated value
$23,800
Report date
23 Sep 2024
Price
$0.1400
Ownership
Direct

Transaction history for Alexandra MacLean in AVENUE THERAPEUTICS, INC.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .